Haemonetics Corp (NYSE:HAE)
| 77.33 Delayed Data As of Mar 22 |  -2.74 / -3.42%Today’s Change | 48.67 Today|||52-Week Range 91.39 | -1.68% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | 2019 | |||
| Operating Activities | Net Income / Starting Line | -55.6M | -26.3M | 45.6M | 55.0M | |
| Depreciation | 89.9M | 89.7M | 89.2M | 109.4M | ||
| Total Other Cash Flow | 114.8M | 97.3M | 11.4M | 44.2M | ||
| Funds From Operations | 148.1M | 153.9M | 140.4M | 222.0M | ||
| Funds From/For Other Operating Expenses | 26.2M | -5.8M | -80.0M | 62.8M | ||
| Net Cash Flow - Operating Activities | 121.9M | 159.7M | 220.4M | 159.3M | ||
| Investing | Capital Expenditures | -102.4M | -76.1M | -74.8M | -119.0M | |
| Fixed Asset Disposal | 637.0K | 2.8M | 11.8M | 2.8M | ||
| Other Investing - Uses | -3.0M | 0.00 | 0.00 | 0.00 | ||
| Net Cash Flow Investing | -104.8M | -73.3M | -63.0M | -116.1M | ||
| Financing | Short Term Borrowings | 2.3M | -50.7M | 671.0K | 15.0M | |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 347.8M | ||
| Long Term Debt Reduction | -22.3M | -42.7M | -61.7M | -266.9M | ||
| Net Proceeds Stock Sale | 18.4M | 33.0M | 40.3M | 13.4M | ||
| Common Preferred Redeemed | -61.0M | 0.00 | -100.0M | -160.0M | ||
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | -62.6M | -60.4M | -120.6M | -50.6M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -12.0K | -1.6M | 3.9M | -3.3M | |
| Net Change In Cash | -45.5M | 26.0M | 36.7M | -7.5M | ||
